Nanoligent closes a €12 million series A round led by Inveready, joined by CDTI, Clave Capital, i&i Biotech Fund, Italian Angels for Growth, and Avanteca Biotech Health services Manufacturing Software Services Investments 06 September 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 14.08M Round investors: i&i Biotech FundAVANTECA PartnersClave MayorInvereadyCDTIItalian Angels for Growth Company: Nanoligent Industry: BiotechHealth servicesManufacturingSoftware Services